SG Americas Securities, LLC

Broker-Dealer

Position in WVE — Wave Life Sciences, Inc.

CIK 1313360 NEW YORK, NY

Position in WVE

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$251,968

+$100,277 QoQ

Shares Held

43,368

+107.3% QoQ

Ownership

0.022%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#131

of 237 holders

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SG Americas Securities, LLC holds $1,085,838,933 across 181 Biotechnology names. WVE ranks #125 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	427,703	$266,689,928
2	VRTX	Vertex Pharmaceuticals Inc / Ma	523,720	$260,147,435
3	URGN	UroGen Pharma Ltd.	2,052,906	$75,546,940
4	CGON	CG Oncology, Inc.	867,465	$61,633,388
5	PTCT	Ptc Therapeutics, Inc.	605,581	$49,397,242
6	ASND	Ascendis Pharma A/S	161,026	$42,948,854
7	RPRX	Royalty Pharma plc	688,590	$38,609,241
8	BNTX	BioNTech SE	347,131	$32,300,539

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$251,968	43,368	+107.3%	Shares	Sole	2026-08-07
2026-03-31	$151,691	20,923	-68.8%	Shares	Sole	2026-04-16
2025-12-31	$1,139,527	67,031	+25.5%	Shares	Sole	2026-01-09
2024-12-31	$660,793	53,419	+46.1%	Shares	Sole	2025-01-17
2024-09-30	$299,816	36,563	-72.7%	Shares	Sole	2024-10-03
2024-06-30	$667,796	133,827	+287.2%	Shares	Sole	2024-07-12
2023-12-31	$174,538	34,562	+33.6%	Shares	Sole	2024-01-12
2023-09-30	$148,741	25,868	-94.7%	Shares	Sole	2023-10-13
2022-03-31	$972,096	486,048	-40.5%	Shares	Sole	2022-04-29
2021-12-31	$2,564,557	816,738	+650.6%	Shares	Sole	2022-02-07
2021-09-30	$533,188	108,814	+877.0%	Shares	Sole	2021-11-01
2020-06-30	$115,936	11,137	—	Shares	Sole	2020-07-20
No filing history on record for this holder in this stock.